| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.4M | -8.4% |
| Cost of Revenue | $1.4M | -10.4% |
| Gross Profit | $1.9M | -6.9% |
| R&D Expense | $54K | +38.7% |
| SG&A Expense | $4.9M | +125.2% |
| Operating Income | -$3.6M | -330.7% |
| Pre-tax Income | -$7.0M | -735.6% |
| Income Tax | $0 | — |
| Net Income | -$7.0M | -735.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $2.8M | +3668.6% |
| Total Assets | $15.5M | — |
| Current Liabilities | $2.3M | -31.4% |
| Total Liabilities | $11.8M | — |
| Stockholders' Equity | $3.8M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.8M | -389.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$2.3M | -1152.0% |
| Financing Cash Flow | $8.9M | +3749.0% |
| Free Cash Flow | -$3.8M | -295.7% |